Thus, to determine whether BLT2 expression is increased in patients with KrasG12D-expressing lung cancer, we performed IHC staining of paraffin-embedded tissue sections derived from 45 patients with malignant lung adenocarcinoma. The gene discussed is LTB4R2; the disease is lung cancer.